Osteoarticular infections on equipment: impact of three probabilistic antibiotic therapy strategies on the digestive microbiota and gastrointestinal colonization with multidrug-resistant bacteria

Status

Not yet recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-513298-29-00

Acronym

22-CONS-01

Enrollment

Registered

2025-02-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarticular infections on equipment

Brief summary

The biodiversity of the gut microbiota will be determined from high-throughput sequencing data of bacterial 16S rDNA

Interventions

DRUGCEFEPIME VIATRIS 2 g

DRUGpoudre pour solution injectable

DRUGMABELIO 500 mg

DRUGpoudre pour solution à diluer pour solution pour perfusion

DRUGDaptomycin Xellia 350 mg powder for solution for injection/infusion

DRUGPiperacillin/Tazobactam Viatris 4 g/0.5 g

DRUGpowder for solution for infusion

DRUGDaptomycin Xellia 500 mg powder for solution for injection/infusion

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
The biodiversity of the gut microbiota will be determined from high-throughput sequencing data of bacterial 16S rDNA	—

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026